Nearly $2 million in funding through Ohio’s Third Frontier program could help a Dublin biomedical company bring
The Third Frontier Commission on Wednesday recommended about $4.9 million in funding for several projects statewide through its biomedical program. The awards, which require final approval from
The two projects that could benefit Central Ohio are:
• A $986,373 award for Cardiox Corp. of Dublin. The company is working on a project to finalize design and testing protocol for a device that detects shunts, or holes in the heart. Detecting the congenital defect, which in some cases can increase the risk of stroke, requires an expensive and elaborate procedure, but
• A $1 million award to Broomfield, Colo.-based Lanx Inc., which is looking to form a Columbus-based Ohio division to move toward commercializing a device that measures range of lumbar motion in patients with back injuries.
The Third Frontier program has created or commercialized more than 600 companies and attracted nearly $5 billion in private investment since its launch in 2002.